Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triostat in Infants After Cardiopulmonary Bypass
NCT02320669Phase 3Completed
- Sponsor
- Seattle Children's
- Start
- Nov 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liothyronine in congenital heart defects (CHD), sponsored by Seattle Children's. Started Nov 2014; status: completed.
02
Drugs
liothyronine
03
Conditions
congenital heart defects (CHD)
Beyond the preview
Go deeper on NCT02320669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02320669.